http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160050305-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
filingDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e19484427ca6c4a0f3c64d6de28e13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3d96dfead2f6c3a306562592ea9c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcea6fdc0ff0ff4b9a1736a076274aea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd4d2f3344d5e196cc36b90f0c173a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65af50ff5535f1229dbb79795bd792d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f60eca94c52b02875f7d26d4d34b01c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fdd3d05bc1eee9a5e4c7178687d7e57
publicationDate 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20160050305-A
titleOfInvention The pharmaceutical composition of increasing solubility by using saccharin
abstract The present invention provides a pharmaceutical composition comprising an ionic liquid consisting of a tryptan compound and saccharin. In the present invention, since the solubility of the tryptic compound is increased by the formation of an ionic liquid by the tryptan compound and saccharin, rapid and high dissolution of the tryptic compound can be expected in the production of a pharmaceutical composition. Further, it is not necessary to use a large amount of an organic solvent and an acidic solvent for the dissolution of the tripartane compound.
priorityDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415829382
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133081
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533490
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502955

Total number of triples: 50.